CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
NCT02992067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 359
Last updated 2019-10-04
Summary
To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.
Conditions
- Lymph Node
- Breastcancer
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
collaborator OTHER -
Zhejiang Cancer Hospital
lead OTHER
Principal Investigators
-
Xingfei Yu, M.D. · Zhejiang Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2017-04-30
- Completion
- 2017-07-31
Countries
- China
Study Locations
More Related Trials
-
21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis
NCT06891651 ·Status: RECRUITING
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
NCT07252986 ·Status: RECRUITING
-
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
NCT04004559 ·Status: UNKNOWN
-
Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
NCT04003558 ·Status: UNKNOWN
-
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
NCT00005058 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA
-
Multimodal Imaging Evaluation System of Axillary Lymph Node Staging and Treatment Strategy for Breast Cancer Neoadjuvant Therapy
NCT04661436 ·Status: UNKNOWN
-
CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC
NCT04457700 ·Status: UNKNOWN
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
NCT04322331 ·Status: UNKNOWN
-
A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps
NCT07244094 ·Status: RECRUITING
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
NCT00721903 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
NCT05623280 ·Status: UNKNOWN
-
Real World Study of Bone Metastases in Patients with Advanced Breast Cancer
NCT06873997 ·Status: COMPLETED
-
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
NCT05550090 ·Status: RECRUITING
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
NCT02610920 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
NCT01668914 ·Status: COMPLETED ·Phase: PHASE3
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN